The MLL-Menin Interaction is a Therapeutic Vulnerability in
Journal
HemaSphere
ISSN: 2572-9241
Titre abrégé: Hemasphere
Pays: United States
ID NLM: 101740619
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
07
02
2023
accepted:
21
06
2023
medline:
31
7
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
Chromosomal translocations involving the
Identifiants
pubmed: 37520776
doi: 10.1097/HS9.0000000000000935
pmc: PMC10378738
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e935Informations de copyright
Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.
Déclaration de conflit d'intérêts
OH received research funding from Syndax. GMM is employee and shareholder of Syndax Pharmaceuticals. All the other authors have no conflicts of interest to disclose.
Références
J Dev Biol. 2021 Oct 13;9(4):
pubmed: 34698191
Blood. 2005 Jul 1;106(1):254-64
pubmed: 15755900
Haematologica. 2015 Jul;100(7):905-13
pubmed: 25911551
Blood Adv. 2022 Apr 12;6(7):2144-2155
pubmed: 35130342
J Clin Invest. 2020 Feb 3;130(2):981-997
pubmed: 31855575
Cancer Cell. 2015 Apr 13;27(4):589-602
pubmed: 25817203
Blood. 2022 Feb 10;139(6):894-906
pubmed: 34582559
Cancer Cell. 2019 Dec 9;36(6):660-673.e11
pubmed: 31821784
Cancer Discov. 2022 Apr 1;12(4):1152-1169
pubmed: 34903620
Blood. 2020 Nov 19;136(21):2442-2456
pubmed: 32589720
Leukemia. 2006 Jul;20(7):1217-20
pubmed: 16642044
Nat Struct Mol Biol. 2021 Feb;28(2):190-201
pubmed: 33479542
Leukemia. 2022 Nov;36(11):2729-2733
pubmed: 36151141
Biomed Pharmacother. 2016 Jul;81:288-294
pubmed: 27261606
N Engl J Med. 2019 Oct 31;381(18):1728-1740
pubmed: 31665578
Mol Biol Cell. 2002 Apr;13(4):1282-97
pubmed: 11950939
Cancer Res. 2016 Feb 1;76(3):619-29
pubmed: 26747896
Leukemia. 2012 Aug;26(8):1829-41
pubmed: 22343733
Cancer Cell. 2016 Nov 14;30(5):737-749
pubmed: 27846391
Oncogene. 2002 Jun 20;21(27):4247-56
pubmed: 12082612
Blood Cancer J. 2021 Jun 16;11(6):112
pubmed: 34135310
Blood Cancer J. 2022 Jan 11;12(1):5
pubmed: 35017466
Blood. 2013 Aug 8;122(6):1017-25
pubmed: 23801631
J Exp Clin Cancer Res. 2022 Jan 24;41(1):34
pubmed: 35073946
Haematologica. 2020 Jul;105(7):1857-1867
pubmed: 31558671
Blood Cancer Discov. 2022 May 5;3(3):194-207
pubmed: 35176137
Science. 2020 Jan 31;367(6477):586-590
pubmed: 32001657
Oncol Lett. 2019 Dec;18(6):6766-6774
pubmed: 31807186
Haematologica. 2021 Feb 01;106(2):630-634
pubmed: 32381579
Nat Genet. 2017 Mar;49(3):451-456
pubmed: 28112737
Haematologica. 2014 Sep;99(9):1465-71
pubmed: 24951466
Blood. 2020 Dec 17;136(25):2958-2963
pubmed: 33331926
Haematologica. 2023 Jan 01;108(1):48-60
pubmed: 35899387
Nat Cell Biol. 2007 Jul;9(7):804-12
pubmed: 17589499
Leuk Res. 2015 Aug;39(8):874-82
pubmed: 26059450
Blood. 2009 Sep 17;114(12):2489-96
pubmed: 19528532
Lancet Oncol. 2019 Jul;20(7):984-997
pubmed: 31175001
Haematologica. 2015 May;100(5):e194-5
pubmed: 25596268
Cell. 2011 Feb 18;144(4):539-50
pubmed: 21335236
J Oncol. 2019 Jul 30;2019:1609128
pubmed: 31467532
Cancer Cell. 2016 Dec 12;30(6):863-878
pubmed: 27889185
Blood. 2020 Jul 23;136(4):387-400
pubmed: 32344427
Blood. 2011 Sep 29;118(13):3645-56
pubmed: 21813447
Blood. 2003 Jun 1;101(11):4529-38
pubmed: 12543865
J Clin Oncol. 2015 Sep 20;33(27):2949-62
pubmed: 26304895
Blood. 2014 Oct 9;124(15):2400-7
pubmed: 25145343
N Engl J Med. 2017 Aug 3;377(5):454-464
pubmed: 28644114
Nature. 2023 Mar;615(7954):920-924
pubmed: 36922593